HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

13.460

+1.31010.78%

Volume:829.29K

Turnover:10.91M

Market Cap:3.80B

PE:-8.91

High:13.500

Open:12.120

Low:12.120

Close:12.150

52wk High:47.980

52wk Low:10.310

Shares:282.46M

HK Float Shares:282.46M

Volume Ratio:1.28

T/O Rate:0.29%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.511

ROE:--

ROA:-40.35%

PB:-3.40

PE(LYR):-8.91

PS:85.18

Loading ...

Overview Company News Filings

Impact Therapeutics announces annual shareholder meeting

IMPACT THERAP-B (07630) to Unveil Phase I/II Trial Results for IMP1734 at 2026 ASCO Annual Meeting

IMPACT Therapeutics highlights IMP1734 Phase 1/2 data at ASCO 2026; monotherapy ORR 14.3%, paclitaxel combo ORR 24.5%

Bulletin Express

Impact Therapeutics says PARP1 inhibitor IMP1734 posts 14.3% ORR in Phase 1/2 monotherapy data at ASCO 2026

Stock Track | Impact Therapeutics-B Soars 15.59% Intraday in Strong Rebound After Post-IPO Profit-Taking

Movement Alert｜Impact Therapeutics-B Rises 13.17% in Regular Trading, Strong Rebound After Post-IPO Profit-Taking

Stock Track | Impact Therapeutics-B Plummets 5.18% Intraday on Post-IPO Profit-Taking and Weak Fundamentals

Movement Alert｜Impact Therapeutics-B Falls 5.77% in Regular Trading, Post-IPO Profit-Taking Pressure Emerges After 108% First-Day Surge

IMPACT THERAP-B Surges Nearly 4% in Late Trading as Core Drug Senaparib Secured National Reimbursement Last December

Stock Track | Impact Therapeutics-B Soars 6.95% Intraday on Medical Insurance Inclusion and Pipeline Progress

Hong Kong Stocks Eke Out Gains; Metis TechBio, Impact Therapeutics Shine on Debut

MT Newswires Live

Impact Therapeutics Jumps 77% in Hong Kong Trading Debut

MT Newswires Live

IMPACT THERAP-B (07630) Debuts on Market, Shares Surge Over 75% at Opening

Stock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription

Shares of Impact Therapeutics Set to Open at HK$35.5 Each in Hong Kong Debut VS Offer Price of HK$20.10 Apiece

THOMSON REUTERS

Impact Therapeutics Nets HK$759.5 Million From Hong Kong IPO Ahead of Debut

MT Newswires Live

Impact Therapeutics Says Final Offer Price Under Global Offering Of Hk$20.10 Per H Share

Impact Therapeutics Inc - Final Offer Price Under Global Offering HK$20.10 per H Share

THOMSON REUTERS

HK Grey Market | Metis TechBio Soars 191%; Impact Therapeutics Jumps 41%

Tiger Newspress

IMPACT THERAP-B (07630) Soars Nearly 120% in Pre-Market Trading, Generating HK$4,792 Per Lot

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/07630/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":13.46,"timestamp":1787299687168,"preClose":12.15,"halted":0,"volume":829286,"delay":0,"changeRate":0.1078189300411523,"floatShares":282461530,"shares":282461530,"eps":-1.5107867902986771,"marketStatus":"Market Closed","change":1.31,"latestTime":"08-21 16:08:07","open":12.12,"high":13.5,"low":12.12,"amount":10914574,"amplitude":0.11358,"askPrice":13.46,"askSize":4000,"bidPrice":13.26,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-1.3535895364975807,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":12.15,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.282420597499764,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.510787,"volumeRatio":1.282420597499764,"shares":282461530,"dividePrice":0,"high":13.5,"amplitude":0.11358,"preClose":12.15,"low":12.12,"week52Low":10.31,"pbRate":"-3.40","psRate":"85.18","week52High":47.98,"institutionHeld":0,"latestPrice":13.46,"committee":-0.73913,"eps":-1.5107867902986771,"divideRate":0,"volume":829286,"delay":0,"ttmEps":-1.3535895364975807,"open":12.12,"prevYearClose":20.1,"prevWeekClose":12.84,"prevMonthClose":13.23,"prevQuarterClose":36.08,"fiveDayClose":12.84,"twentyDayClose":11.5,"sixtyDayClose":37.74,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"07630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1782230400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-08-21","current":-9.94393,"percent":0.681159,"low":-34.323153,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"high":-8.821219,"avg":-20.607242,"sd":9.633676,"marketCap":3717182649},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-18","current":-29.78235,"twenty":-32.303072,"median":-30.338658,"eighty":-29.742668,"marketCap":10218109810},{"date":"2026-06-26","current":-29.297581,"twenty":-32.241427,"median":-30.11999,"eighty":-29.607619,"marketCap":10002701008},{"date":"2026-07-03","current":-16.26247,"twenty":-32.218614,"median":-29.994357,"eighty":-29.297581,"marketCap":5556442415},{"date":"2026-07-10","current":-15.780707,"twenty":-31.493905,"median":-29.916258,"eighty":-25.475578,"marketCap":5385220035},{"date":"2026-07-17","current":-11.297625,"twenty":-31.022068,"median":-29.816044,"eighty":-15.922995,"marketCap":3869073471},{"date":"2026-07-24","current":-9.271485,"twenty":-30.958502,"median":-29.609087,"eighty":-15.602668,"marketCap":3175898995},{"date":"2026-07-31","current":-10.646015,"twenty":-30.630104,"median":-29.369689,"eighty":-13.307417,"marketCap":3653664669},{"date":"2026-08-07","current":-10.047131,"twenty":-30.493855,"median":-29.24895,"eighty":-10.58915,"marketCap":3454825776},{"date":"2026-08-14","current":-10.299125,"twenty":-30.36699,"median":-25.475578,"eighty":-10.316459,"marketCap":3545960269},{"date":"2026-08-21","current":-10.772628,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"marketCap":3717182649}],"updateTime":1787449124564},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640905626","title":"Impact Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640905626","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640905626?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:34","pubTimestamp":1780482850,"startTime":"0","endTime":"0","summary":"Impact Therapeutics will hold its annual general meeting in Shanghai on June 25, 2026.Shareholders will vote on the 2025 board work report, the accountant’s report for 2025, and the 2025 profit distribution plan.Other items include re-appointing Ernst & Young as auditor for 2026, proposed amendments to the articles of association.Resolutions also cover a general mandate to issue shares up to 20% of shares in issue, plus a mandate to repurchase up to 10% of H shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Therapeutics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 03, 2026, and is solely responsible for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL1q597b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190630928","title":"IMPACT THERAP-B (07630) to Unveil Phase I/II Trial Results for IMP1734 at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1190630928","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190630928?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:40","pubTimestamp":1780274422,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) announced that the latest Phase I/II clinical data for the highly selective PARP1 inhibitor IMP1734 (also known as EIK1003) will be presented in a poster session at the 2026...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199921042","title":"IMPACT Therapeutics highlights IMP1734 Phase 1/2 data at ASCO 2026; monotherapy ORR 14.3%, paclitaxel combo ORR 24.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199921042","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199921042?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:23","pubTimestamp":1780273420,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. (IMPACT Therapeutics) released updated Phase 1/2 clinical results for its PARP1-selective inhibitor IMP1734 (EIK1003) during the 2026 American Society of Clinical Oncology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640890009","title":"Impact Therapeutics says PARP1 inhibitor IMP1734 posts 14.3% ORR in Phase 1/2 monotherapy data at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640890009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640890009?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:06","pubTimestamp":1780272383,"startTime":"0","endTime":"0","summary":"Impact Therapeutics presented Phase 1/2 data for PARP1 inhibitor IMP1734 at the 2026 ASCO Annual Meeting.Monotherapy showed early signs of durable tumor shrinkage in heavily pretreated patients, with a generally favorable safety profile.A separate cohort combining IMP1734 with weekly paclitaxel showed antitumor activity despite extensive prior taxane use.The combination produced manageable safety in an advanced-line setting, with severe side effects largely consistent with chemotherapy-driven blood toxicities.Data support a strategy to pair a PARP1-selective inhibitor with cytotoxic chemotherapy, an approach the company framed as difficult with older PARP drugs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Therapeutics Inc. pu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLgDcQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107678797","title":"Stock Track | Impact Therapeutics-B Soars 15.59% Intraday in Strong Rebound After Post-IPO Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1107678797","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107678797?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:16","pubTimestamp":1779419803,"startTime":"0","endTime":"0","summary":"Impact Therapeutics-B's stock surged 15.59% intraday, staging a significant rebound in the Hong Kong market. The movement represents a recovery following several sessions of profit-taking pressure...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119583328","title":"Movement Alert｜Impact Therapeutics-B Rises 13.17% in Regular Trading, Strong Rebound After Post-IPO Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1119583328","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119583328?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:14","pubTimestamp":1779419673,"startTime":"0","endTime":"0","summary":"On May 22, Impact Therapeutics-B (07630.HK) rose 13.17% in regular trading, trading at HK$35.68 per share, with trading volume of approximately HK$8.79 million. The stock staged a strong rebound...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116682247","title":"Stock Track | Impact Therapeutics-B Plummets 5.18% Intraday on Post-IPO Profit-Taking and Weak Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=1116682247","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116682247?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:32","pubTimestamp":1779330773,"startTime":"0","endTime":"0","summary":"Impact Therapeutics-B's stock plummeted 5.18% during intraday trading on Thursday.The decline reflects mounting profit-taking pressure following the company's explosive IPO debut. Impact Therapeutics...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162485828","title":"Movement Alert｜Impact Therapeutics-B Falls 5.77% in Regular Trading, Post-IPO Profit-Taking Pressure Emerges After 108% First-Day Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1162485828","media":"Market Focus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162485828?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:31","pubTimestamp":1779330674,"startTime":"0","endTime":"0","summary":"On May 21, Impact Therapeutics-B (07630.HK) declined 5.77% in regular trading, trading at HK$35.7 per share, with trading volume of approximately HK$5.39 million.The decline reflects mounting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186114537","title":"IMPACT THERAP-B Surges Nearly 4% in Late Trading as Core Drug Senaparib Secured National Reimbursement Last December","url":"https://stock-news.laohu8.com/highlight/detail?id=1186114537","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186114537?lang=en_us&edition=fundamental","pubTime":"2026-05-19 15:52","pubTimestamp":1779177169,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) rose nearly 4% in late trading. As of press time, the stock was up 3.93% to HK$39.66, with a turnover of HK$13.8225 million. Public information indicates that IMPACT THERAP-B...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","VXUS","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147308533","title":"Stock Track | Impact Therapeutics-B Soars 6.95% Intraday on Medical Insurance Inclusion and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1147308533","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147308533?lang=en_us&edition=fundamental","pubTime":"2026-05-15 09:41","pubTimestamp":1778809313,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (stock code: 07630) saw its stock price soar by 6.95% during intraday trading on Friday, extending its strong performance since its recent listing.The surge is attributed to multiple...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635659204","title":"Hong Kong Stocks Eke Out Gains; Metis TechBio, Impact Therapeutics Shine on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2635659204","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635659204?lang=en_us&edition=fundamental","pubTime":"2026-05-13 16:43","pubTimestamp":1778661780,"startTime":"0","endTime":"0","summary":"Hong Kong stocks edged higher on Wednesday ahead of the meeting between U.S. President Donald Trump and Chinese President Xi Jinping.The Hang Seng Index added 0.2%, or 40.53 points, to close at 26,388","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["513600","MCHmain","02833","BK4007","HHImain","07666","MHImain","HSI","07630","BK4539","HSTECH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227755","title":"Impact Therapeutics Jumps 77% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227755?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:52","pubTimestamp":1778637138,"startTime":"0","endTime":"0","summary":"Impact Therapeutics' (HKG:7630) shares opened 76.6% above their initial public offering price in a solid Hong Kong debut on Wednesday morning.The Chinese biotech company opened at HK$35.50 per share, compared with the offer price of HK$20.10.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","BK4007","07630","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108590959","title":"IMPACT THERAP-B (07630) Debuts on Market, Shares Surge Over 75% at Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1108590959","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108590959?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:39","pubTimestamp":1778636342,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) made its debut on the stock exchange. According to the announcement, the shares were priced at HKD 20.1 each, with a total of 41.977 million shares issued. Each board lot...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175801097","title":"Stock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1175801097","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175801097?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:33","pubTimestamp":1778636029,"startTime":"0","endTime":"0","summary":"Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.The sharp rise was driven by extraordinary investor demand during the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635222245","title":"Shares of Impact Therapeutics  Set to Open at HK$35.5 Each in Hong Kong Debut VS Offer Price of HK$20.10 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2635222245","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635222245?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:21","pubTimestamp":1778635264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL4N41Q02Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635257392","title":"Impact Therapeutics Nets HK$759.5 Million From Hong Kong IPO Ahead of Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2635257392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635257392?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:03","pubTimestamp":1778623413,"startTime":"0","endTime":"0","summary":"Impact Therapeutics (HKG:7630) raised HK$759.5 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$20.10 per H-share, near the lower end of the of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPOS","SPCX","BK4539","07630","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634024803","title":"Impact Therapeutics Says Final Offer Price Under Global Offering Of Hk$20.10 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2634024803","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634024803?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:02","pubTimestamp":1778598158,"startTime":"0","endTime":"0","summary":"May 12 (Reuters) - IMPACT Therapeutics Inc <7630.HK>::*FINAL OFFER PRICE UNDER GLOBAL OFFERING  HK$20.10 PER H SHARE*Further company coverage: 7630.HK* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nRSD8g33Gn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634230217","title":"Impact Therapeutics Inc - Final Offer Price Under Global Offering  HK$20.10 per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2634230217","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634230217?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:53","pubTimestamp":1778594027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168482740","title":"HK Grey Market | Metis TechBio Soars 191%; Impact Therapeutics Jumps 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168482740","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168482740?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:34","pubTimestamp":1778574876,"startTime":"0","endTime":"0","summary":"$Metis TechBio(07666)$, one of the \"Top Three AI Drug Discovery\" companies in Mainland China, soared 191% in Hong Kong’s grey market trading.Founded in 2020, Metis TechBio focuses on the delivery and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","07666"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119614246","title":"IMPACT THERAP-B (07630) Soars Nearly 120% in Pre-Market Trading, Generating HK$4,792 Per Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1119614246","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119614246?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:22","pubTimestamp":1778574135,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) is scheduled to list on the Hong Kong stock exchange on Wednesday, May 13. At the time of writing, pre-market trading indicates a price of HK$44.06, representing a surge of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":70,"code":"91000000","status":"200"}]}}